Raymund S. Cuevo, M.D.

Curriculum Vitae

2/12/2024

OFFICES:

Inova Schar Cancer Center

Department of Inova Fairfax Hospital

Skyline Clinic

8081 Innovation Park Drive

Falls Church, VA 22042

MEDICAL LICENSES

State of Virginia

License number 0101058828, issued 01/04/1999

CERTIFICATIONS

Diplomate in Internal Medicine, 9/1989, indefinitely active

Diplomate in Hematology, 11/1989 – 12/2024

Diplomate in Oncology, 11/1997 – 12/2032

POST GRADUATE TRAINING

Hematology/Oncology Fellowship training, 07/1989 – 06/1992

Duke University Medical Center

Durham, North Carolina 27710

Medicine Internship and Residency, 07/1986 – 06/1989

Duke University Medical Center

Durham, North Carolina 27710

EDUCATION

Yale University Medical School, MD degree, 09/1982 – 05/1986

New Haven, Connecticut 06520

Yale College, BS and MS degrees in Molecular Biophysics and Biochemistry, 09/1978 – 05/1982

New Haven, Connecticut 06520

Graduated cum laude with distinction in the major, 05/1982

PROFESSIONAL EXPERIENCE

Practicing physician, 1/11/2016 - present

Inova Schar Cancer Center

8081 Innovation Park Drive

Falls Church, Virginia 22042

Practicing physician and practice group partner, 05/1999 – 01/2016

Medical Oncology & Hematology Associates of Northern Virginia, Ltd.

8501 Arlington Blvd, Suite 340

Fairfax, Virginia 22031

Practicing physician, 08/1997 – 04/1999

Cardinal Healthcare, P.A

Raleigh, North Carolina 27710

Associate, Department of Medicine, 09/1992 – 07/1997

Duke University Medical Center

Durham, North Carolina 27710

Instructor Department of Medicine, 07/1992 – 09/1992

Duke University Medical Center

Durham, North Carolina 27710

COMMITTEES

Member, System wide Pharmacy and Therapeutics Committee

Inova Health System, 01/2014 – present

Inova Schar Cancer Center Pharmacy & Therapeutics committee member

Schar Cancer Institute, Inova Fairfax Hospital, 01/2018 - present

Member, Patient Blood Management Committee

Inova Fairfax Hospital. 07/2010 – present

CLINICAL TRIALS

A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma.  Sub-investigator

SCHOLARSHIP AND RESEARCH

Research Grants

“Molecular genetic analysis of a yeast Rb-like pathway.”

National Cancer Institute Grant #CA016484

August 1992 – June 1997

Publications

Mary Steimer, Jessica Leabo, Hongkun Wang, David Heyer, Nancy Bowles, Laura Matthews, Timothy L Cannon, Raymund Cuevo, William B. Ershler, Danielle Shafer, Sekwon Jang, Angela Pennisi, Amjaad Al-Hussain, Kirby Farrell & John F. Deeken, 2022, Remote Home Monitoring of Patients with Cancer During the COVID-19 Pandemic.  Oncology Issues, 37:3 20-26.

Jess F. Peterson, Rui R. He, Hassan Nayer, Raymund S. Cuevo, James B. Smadbeck, George Vasmatzis, Patria T. Greipp, Rhett P.l Ketterling, Nicole L. Hoppman, Linda B Baughn, 2019, Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy.  Cancer Genetics 237:  51-54.

Rui R. He, Zacharia Nayer, Matthew Hogan, Raymund S. Cuevo, Kimberly Woodward, David Heyer, Christine A Curtis, and Jess F. Peterson.  2019.  Immunotherapy-(Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia.  Hindawi Case Reports in Hematology.  Volume 2019, Article ID 7394619, 4 pages (https://doi.org/10.1155/2019/7394619).

Raymund S. Cuevo, Stephen Garrett, and Jonathan M. Horowitz, 1997.  Detection and Functional Characterization of p180, A Novel Cell-Cycle Regulated Yeast Transcription Factor That Binds Retinoblastoma Control Elements (RCEs).  The Journal of Biological Chemistry, 272: 3813-3822

Raymund S. Cuevo, John B. Ewell, and Frederick T. Gates, III.  1985.  Measurement of Residual Host Cell DNA in Lots of Inactivated Poliovirus Vaccine.  In: Abnormal Cell, New Producs, and Risk.  In Vitro cellular and developmental biology. Monograph 6: 76-78

Clayton H. Shatney, Gordon Read, Raymund Cuevo, and Joseph F. Formeister.  1981.  The Natural Leukocyte Response to Hemorrhagic Shock.  Advances in Shock Research, 5: 79-88